But we did get to $23 without the approval. As we lived through the FUD attack, the coast should be clear to regain at minimum, the high we achieved earlier. Analysts have since given price targets of $28 and $35. $17.50+ makes no sense.
ILove...yes $23 on euphoria...as we all experienced after years of agony. But one thing seems to hold true...not a lotta love for Amarin by ws. We are still in prove it to me stage...dont care bout the rah rah statistics. So the question is, how long does it take to prove it to me...either by bo or scripts. Without FDA approval, I don’t think scripts will be nearly as robust as they could be...and I say this because of greedy insurance companies....
News 
Market Data 
Discover 
